Yingli Singapore to Supply Multicrystalline PV Modules to Amcorp Power

Yingli Green Energy Holding Company Limited ("Yingli Green Energy" or the "Company"), a leading solar energy company and one of the world's largest vertically integrated photovoltaic ("PV") manufacturers, which markets its products under the brand "Yingli Solar", announced today that its wholly-owned subsidiary, Yingli Green Energy Singapore Company Pte. Limited ("Yingli Singapore") will supply 10.269 MW of multicrystalline PV modules to Amcorp Power Sdn. Bhd. ("Amcorp Power"), which is a subsidiary of Amcorp Group Berhad, an investment holding company based in Malaysia.

Located at Gemas, Negri Sembilan, the 10.269 MW PV project (the "Project") is owned and managed by Amcorp Power. The Project is the largest single site PV power plant in Malaysia.

Spanning an area of approximately 34 acres, the Project will utilize around 41,076 pieces of YGE 60 Cell Series multicrystalline module with peak power of 250 watt. It is estimated that the 10.269 MW PV power plant will be able to generate approximately 13.6 million kWh of clean electricity per annum.

"We're delighted to make this breakthrough in Southeast Asia," said Mr. Liansheng Miao, Chairman and Chief Executive Officer of Yingli Green Energy. "Southeast Asia is a very promising PV market given its rich solar radiation, serious lack of electricity and governments' strong interest in renewable energy applications. By leveraging our regional headquarters in Singapore and overwhelming brand influence, we look forward to serving our customers with high quality products and expanding our exposure to this region."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.